Par Drugs and Chemicals Limited (PAR) Fair Value & Analysis
Healthcare · IN · Market cap ₹1.1B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price +3.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹76.70 – ₹115.72 · fair‑value band ₹154.08 – ₹265.91 · the ₹88.53 price screens below the ₹219.53 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Par Drugs and Chemicals Limited (PAR) currently trades at ₹88.53, while our model-based Fair Value estimate is ₹219.53 — implying the stock looks roughly 148.0% undervalued today. We read business quality at 58/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Par Drugs and Chemicals Limited generated revenue of ₹1.0B at a net margin of 12.7%. Revenue declined 12.2% year over year. It earns a return on equity of 12.4%. The balance sheet holds a net cash position of ₹418M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Par Drugs and Chemicals Limited reported revenue of ₹1.0B in FY2026 versus ₹746M in FY2022, a compound +8.6%/yr. Reported net income was ₹131M in FY2026, compounding +9.2%/yr from FY2022.
Is PAR fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,786 | ₹991.46 | -44% |
| Zoetis Inc Z1TS34 | R$25.93 | R$19.70 | -24% |
| Hansoh Pharmaceutical Group 3692 | HK$29.30 | HK$23.90 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,639 | ₹1,281 | -81% |
| Swedish Orphan Biovitrum AB SOBI | kr 435.00 | kr 285.77 | -34% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Par Drugs and Chemicals Limited (PAR) undervalued?
What is the fair value of PAR?
What is the quality score of PAR?
What is the revenue of Par Drugs and Chemicals Limited (PAR)?
What is the net profit margin of PAR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.